Printer Friendly

Articles from M2 Pharma (February 5, 2019)

1-25 out of 25 article(s)
Title Author Type Words
Ambu's board member to leave. 107
Antibe Therapeutics Enters CDN 5m Bought Deal Offering. 517
ArTara Therapeutics Adds to Leadership Team and Board of Directors. 446
AstraZeneca gains EU marketing recommendation for Forxiga. 232
BioLineRx wins US FDA orphan drug designation for BL-8040 to treat pancreatic cancer. 235
Cedilla Therapeutics Names Dawson as Chief Human Resources Officer. 241
Co-Diagnostics Closes USD 5.5m Registered Direct Offering. 258
Co-Diagnostics Inc raises USD5.5m registered direct offering. 148
Cyxone awarded US divisional patent for drug candidate T20K in MS. 187
doTERRA elects Russell J. Osguthorpe, MD as CMO and VP. 170
EMD Serono names new senior vice president, chief compliance officer North America. 259
EMMAC Life Sciences Cleared to Make Turnkey GMP Facility in Malta to be Group Import and Distribution Hub. 193
Genentech Submits Supplemental Biologics License Application to FDA for Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Disease After Neoadjuvant Treatment. 212
Gilead Sciences reports 11% rise in Q1 2019 dividend. 128
Ligand Invests USD 3m in Dianomi Therapeutics. 669
Neurotrope signs cooperative research and development agreement with the National Cancer Institute for Bryostatin-1 research and clinical development. 323
Newron Pharmaceuticals' STARS clinical study completes patient enrolment. Clinical report 235
Pack Health elects Jamie DeMaria PhD MBA as VP of Strategy. 125
Pack Health names new vice president of strategy. 119
Reaction Biology Corporation closes acquisition of ProQinase GmbH. 217
Syntrix announces USD3.4m NIH grant to launch Phase 1/2 trial of SX-682 in MSD patients. 284
Trevi Therapeutics Inks License Agreements for use of Nalbuphine for the Treatment of Levodopa-Induced Dyskinesia in Parkinson's Disease. 656
Valbiotis Expands Board of Directors with the Appointment of Murielle Cazaubiel. 362
Verseon Reports First Dosing in Phase 1 Trial on New Precision Oral Anticoagulant. 538
VLP Therapeutics to launch first clinical trial of VLPM01 malaria vaccine at the Walter Reed Army Institute of Research. 272

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters